Amarin Corp Plc (AMRN)

[Pharmacydude]

TTE
Generic’s API supplier stated in their q3 cc that they would be able to supply 100 tons of API shortly and max out around 300 tons/yr over the next 2 years. They said they had a near monopoly on generic supply so we see a total of 50,000 scripts/week going to generics over the next 2 years. Anything over 50,000 goes to Amarin with over 1,000 ton capacity. Efficacy in COVID would cause a jump in sales that would not change generics limited ability to meet demand (50,000/wk). Generics will always be able to sell whatever volume they can produce due to automatic substitution policies in many states. It’s all about API.